Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Jasper Therapeutics, Inc. (JSPR)

Jasper Therapeutics warrant offer: 68.94% of warrants tendered at $0.324 each

Neutral Impact 2 of 5 financing

Jasper Therapeutics announced the results of its offer to purchase all outstanding warrants issued in its September 18, 2025 underwritten public offering, at $0.324 in cash per warrant, which expired on November 7, 2026. A total of 8,510,658 warrants were properly tendered, about 68.94% of the outstanding warrants, and the company expects to pay $2,757,453.19 in cash for them.

Key points

  • 8,510,658 warrants were properly tendered and not withdrawn, about 68.94% of outstanding warrants.
  • Offer price was $0.324 in cash per warrant, without interest; the offer expired at 12:00 a.m. Eastern Time on November 7, 2026.
  • The company expects to pay an aggregate of $2,757,453.19 in cash, to be made promptly.
  • The offer was described in a Schedule TO originally filed with the SEC on October 7, 2026.

The filing

CompanyJasper Therapeutics, Inc. (JSPR)
Form8-K, current report
Filed with the SECNov 9, 2026, 8:05 AM ET
Accession number0001213900-26-117230

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:31 AM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.